Carregant...
Bazedoxifene-Induced Vasodilation and Inhibition of Vasoconstriction is Significantly Greater than Estradiol
OBJECTIVE: A new strategy for menopausal hormone therapy replaces medroxyprogesterone with the selective estrogen receptor modulator bazedoxifene. While the agonist or antagonist activity of bazedoxifene has been examined in other tissues, the current study explored the impact of bazedoxifene on res...
Guardat en:
| Publicat a: | Menopause |
|---|---|
| Autors principals: | , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6344253/ https://ncbi.nlm.nih.gov/pubmed/30130290 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/GME.0000000000001195 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|